Molgramostim

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by OAbot (talk | contribs) at 06:23, 12 April 2020 (Open access bot: doi added to citation with #oabot.). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Molgramostim
Clinical data
AHFS/Drugs.comInternational Drug Names
ATC code
Identifiers
CAS Number
ChemSpider
  • none
UNII
  (verify)

Molgramostim is a recombinant granulocyte macrophage colony-stimulating factor which functions as an immunostimulator.[1][2]

References

  1. ^ Quittet P, Ceballos P, Lopez E, et al. (2006). "Low doses of GM-CSF (molgramostim) and G-CSF (filgrastim) after cyclophosphamide (4 g/m2) enhance the peripheral blood progenitor cell harvest: results of two randomized studies including 120 patients". Bone Marrow Transplant. 38 (4): 275–84. doi:10.1038/sj.bmt.1705441. PMC 2100150. PMID 16883311.
  2. ^ Orozco H, Arch J, Medina-Franco H, et al. (2006). "Molgramostim (GM-CSF) associated with antibiotic treatment in nontraumatic abdominal sepsis: a randomized, double-blind, placebo-controlled clinical trial". Archives of Surgery. 141 (2): 150–3, discussion 154. doi:10.1001/archsurg.141.2.150. PMID 16490891.


Stub icon

This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Molgramostim&oldid=950460945"